NIH-funded research NIH-funded research

Understanding how cells repair DNA damage

Official title: Dissecting the DNA Damage Response with Functional Proteomics

Funded at University of Texas Hlth Science Center · NIH-11011169 · Data updated 2026-11-12

This study is looking at how our cells fix damaged DNA and how certain proteins help with this process, which is really important for keeping us healthy and preventing diseases like cancer.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center
NIH-funded
Lab location1 site (San Antonio, United States)
Project startJanuary 22, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$408,179
NIH project number1R35GM156189-01
Project IDNIH-11011169 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a family history of breast or ovarian cancer, particularly those with mutations in the BRCA1 gene.

Less likely to help

Patients without any known genetic predisposition to DNA damage-related conditions or those not affected by cancer may not receive direct benefits from this research.

What this research studies

This research investigates the DNA damage response (DDR), focusing on how proteins involved in DNA repair are modified and regulated. Using advanced mass spectrometry techniques, the study aims to identify new proteins and interactions that play a role in the DDR. By examining how specific kinases and phosphatases affect these processes, the research seeks to uncover the mechanisms that control DNA repair, which is crucial for maintaining cellular health and preventing diseases like cancer.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for enhancing DNA repair mechanisms, potentially benefiting patients with cancer or genetic disorders related to DNA damage.

How similar studies have gone: Previous research has shown success in understanding DNA damage response mechanisms, but this study aims to explore novel regulatory pathways that have not been extensively tested.

Where this research is happening

  • University of Texas Hlth Science Center
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Kim, Minkyu — University of Texas Hlth Science Center
  • Study coordinator: Kim, Minkyu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.